Related Experiment Videos
Ligneous conjunctivitis
Documenta Ophthalmologica. Advances in Ophthalmology
|December 30, 1986
Summary
This case study reports a novel treatment for ligneous conjunctivitis, a rare inflammatory condition. Azathioprine (Imuran) effectively managed recurrent granulomatous inflammation in a patient unresponsive to conventional therapies.
Area of Science:
- Ophthalmology
- Immunology
Background:
- Ligneous conjunctivitis is a rare, chronic inflammatory condition characterized by thick, woody exudates.
- Recurrent granulomatous inflammation of the conjunctiva and vocal cords presents a significant treatment challenge.
Observation:
- A 65-year-old female presented with chronic, recurrent granulomatous conjunctival inflammation and vocal cord polyps.
- Previous treatments, including surgical removal and conventional therapies for ligneous conjunctivitis, were unsuccessful, with disease progression to the fellow eye.
Findings:
- Histological diagnosis of ligneous conjunctivitis was established in 1981.
- Treatment with azathioprine (Imuran) initiated in 1984 resulted in sustained remission of conjunctival and vocal cord inflammation.
Implications:
- Azathioprine (Imuran) represents a potential new therapeutic option for refractory cases of ligneous conjunctivitis.
- This case highlights the importance of considering immunomodulatory agents in managing complex inflammatory ocular conditions.